Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders.
2018Digestive diseases (Basel, Switzerland)
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Dynamics of metatranscription in the inflammatory bowel disease gut microbiome.
2018Nature microbiology
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?
2018Microbiome
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Adsorptive granulomonocytapheresis alters the gut bacterial microbiota in patients with active ulcerative colitis.
2021Journal of clinical apheresis
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Study of microbiome changes in patients with ulcerative colitis in the Central European part of Russia.
2021Heliyon
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Gut microbiota in mucosa and feces of newly diagnosed, treatment-naïve adult inflammatory bowel disease and irritable bowel syndrome patients.
2022Gut microbes
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Bacterial and fungal biomarkers in irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD): trans-kingdom interactions, Blastocystis carriage, and enterotype-succinotype stratification.
2026Gut pathogens
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
